These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2427541)

  • 21. C1s-induced vascular permeability in C2-deficient guinea pigs.
    Strang CJ; Auerbach HS; Rosen FS
    J Immunol; 1986 Jul; 137(2):631-5. PubMed ID: 3487577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of consumption kinetics of the C4 and C2 components of complement by immune complexes "in vitro" (author's transl)].
    Roncato M; Maillet F; Peltier AP
    Pathol Biol (Paris); 1981 Feb; 29(2):95-9. PubMed ID: 7015243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency.
    Boeckler P; Milea M; Meyer A; Uring-Lambert B; Heid E; Hauptmann G; Cribier B; Lipsker D
    Br J Dermatol; 2005 Feb; 152(2):265-70. PubMed ID: 15727637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing the endocytosis of immune complexes.
    van Es LA; Daha MR
    Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation.
    Lachmann PJ; Halbwachs L
    Clin Exp Immunol; 1975 Jul; 21(1):109-14. PubMed ID: 52423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of guinea pig macrophages bearing surface C4 by fluorescence-activated cell sorting: correlation between surface C4 antigen and C4 protein secretion.
    Auerbach HS; Lalande ME; Latt S; Colten HR
    J Immunol; 1983 Nov; 131(5):2420-6. PubMed ID: 6355294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
    Perrin LH; Shiraishi S; Stroud RM; Lambert PH
    J Immunol; 1975 Jul; 115(1):32-5. PubMed ID: 1171140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Complement deficiencies].
    Meri S
    Duodecim; 1994; 110(2):185-94. PubMed ID: 7555791
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages.
    Daha MR; Van Es LA
    Immunology; 1981 Jul; 43(3):513-8. PubMed ID: 7251062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).
    Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR
    Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [B, C2 and C4 complement factors, the HLA system and diseases. Genetic relation].
    Doutre MS
    Pathol Biol (Paris); 1983 Sep; 31(7):622-30. PubMed ID: 6355995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement and sepsis.
    Gutiérrez-Fernández J; Maroto MC; Piédrola G; Zamora E
    Allergol Immunopathol (Madr); 1987; 15(3):145-9. PubMed ID: 3661354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
    Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
    J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetanus toxoid-anti-tetanus toxoid complexes: a potential model to study the complement transport system for immune complex in humans.
    Paccaud JP; Steiger G; Sjöholm AG; Spaeth PJ; Schifferli JA
    Clin Exp Immunol; 1987 Aug; 69(2):468-76. PubMed ID: 2958199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new haemolytic assay for the second component of complement (C2) in human serum.
    Naish PF; Barratt J; Collins C
    Clin Exp Immunol; 1976 Sep; 25(3):487-9. PubMed ID: 963910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.